PURDUE PHARMA LP Company Profile

✉ Email this page to a colleague

PURDUE PHARMA LP has ten approved drugs.

There are sixty-five US patents protecting PURDUE PHARMA LP drugs.

There are four hundred and eighty-two patent family members on PURDUE PHARMA LP drugs in fifty-one countries and one supplementary protection certificate in one country.

International Patents:	482
US Patents:	65
Tradenames:	10
Ingredients:	9
NDAs:	10
Patent Litigation for PURDUE PHARMA LP:	See patent lawsuits for PURDUE PHARMA LP

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-004	Nov 20, 2014	AB	RX	Yes	No	11,304,909	⤷ Sign Up				⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-004	Nov 20, 2014	AB	RX	Yes	No	9,095,615	⤷ Sign Up	Y			⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-005	Nov 20, 2014	AB	RX	Yes	No	9,770,416	⤷ Sign Up	Y			⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-004	Nov 20, 2014	AB	RX	Yes	No	9,545,380	⤷ Sign Up				⤷ Sign Up
Purdue Pharma Lp	OXYCONTIN	oxycodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022272-005	Apr 5, 2010		RX	Yes	Yes	9,492,393	⤷ Sign Up				⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-006	Nov 20, 2014	AB	RX	Yes	No	8,808,740	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Purdue Pharma Lp	OXYCONTIN	oxycodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022272-007	Apr 5, 2010	5,508,042	⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-007	Nov 20, 2014	9,669,024	⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-001	Nov 20, 2014	9,517,236	⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-003	Nov 20, 2014	6,733,783	⤷ Sign Up
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-006	Nov 20, 2014	6,733,783	⤷ Sign Up
Purdue Pharma Lp	BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306-001	Jun 30, 2010	6,264,980	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Tablets	20 mg, 60 mg, and 120 mg	➤ Subscribe	2015-04-15
➤ Subscribe	Extended-release Tablets	15 mg	➤ Subscribe	2007-02-15
➤ Subscribe	Transdermal System	15 mcg/hr	➤ Subscribe	2013-12-16
➤ Subscribe	Extended-release Tablets	30 mg, 40 mg, 80 mg, and 100 mg	➤ Subscribe	2015-05-08
➤ Subscribe	Extended-release Tablets	30 mg and 60 mg	➤ Subscribe	2007-01-03
➤ Subscribe	Transdermal System	5 mcg/hr, 10 mcg/hr, and 20 mcg/hr	➤ Subscribe	2013-06-06

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1685839	92292	Luxembourg	⤷ Sign Up	PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.